Serum proteomic analysis across premenopausal, perimenopausal, and postmenopausal women identified 16 proteins — predominantly inflammatory, alongside synaptic, metabolic, and Alzheimer's-related markers — that shift with menopausal stage independent of chronological age. Nine of these replicated in a UK Biobank cohort of nearly 3,000 women, and a composite proteomic score tracked with later cognitive outcomes. The findings position the menopausal transition as a measurable and potentially modifiable interval in brain aging.
Key Points
- Sixteen serum proteins shift across menopause, mostly inflammatory markers
- Menopausal stage, not chronological age, drove protein changes
- Nine proteins replicated in nearly 3,000 UK Biobank women
Longevity Analysis
Midlife hormonal reorganization produces a detectable inflammatory and synaptic signature in blood years before cognitive decline becomes clinically apparent, turning a life stage usually described in symptom terms into something quantifiable. Estradiol and progesterone withdrawal does not act on the ovaries alone — it propagates through immune signaling, metabolic regulation, and synaptic maintenance simultaneously, which explains why cognitive complaints during this period are so common and so often dismissed. Reading these markers accurately during the transition opens a defined window for intervention, when inflammatory load and metabolic drift remain tractable rather than entrenched.
Original published by LifeSpan.io, by Anna Drangowska-Way.